The PROCLIPI international registry of early‐stage mycosis fungoides identifies substantial diagnostic delay in most patients
Julia Scarisbrick(University Hospital of Zurich), Andrew Bates, M. Beylot‐Barry(Université de Bordeaux), Vasiliki Nikolaou(European Organisation for Research and Treatment of Cancer), Deborah Turner, Nicola Pimpinelli(University of Florence), Michael Weichenthal(Christian-Albrechts-Universität zu Kiel), Vanessa Gargallo(European Organisation for Research and Treatment of Cancer), Ágota Szepesi(Semmelweis University), Stefanie Porkert(Peter MacCallum Cancer Centre), Triantafyllia Κoletsa(Aristotle University of Thessaloniki), H. Miles Prince(Peter MacCallum Cancer Centre), Robert Knobler(Medical University of Vienna), Márta Marschalkó(European Organisation for Research and Treatment of Cancer), Pablo L. Ortiz‐Romero(Hospital Universitario 12 De Octubre), Marion Wobser(Universitätsklinikum Würzburg), Teresa Estrach(Hospital Clínic de Barcelona), René Stranzenbach(European Organisation for Research and Treatment of Cancer), Aikaterini Patsatsi(Papageorgiou General Hospital), Ulrike Wehkamp(European Organisation for Research and Treatment of Cancer), Eva Geissinger(European Organisation for Research and Treatment of Cancer), Emmilia Hodak(Rabin Medical Center), Christina Mitteldorf(European Organisation for Research and Treatment of Cancer), Eileen Parry(European Organisation for Research and Treatment of Cancer), Pietro Quaglino(Department of Medical Sciences), Evangelia Papadavid(National and Kapodistrian University of Athens), M. Bagot(Inserm), Emmanuella Guenova(Johannes Kepler University of Linz), Jeremy P. Harris(University of California, Irvine Medical Center), Iris Amitay(European Organisation for Research and Treatment of Cancer), Hadas Prag Naveh(European Organisation for Research and Treatment of Cancer), Cristina Muniesa(Peter MacCallum Cancer Centre), Maxime Battistella(Peter MacCallum Cancer Centre), C. Ram‐Wolff(European Organisation for Research and Treatment of Cancer), Carlo Tomasini(European Organisation for Research and Treatment of Cancer), Andrea Combalía(European Organisation for Research and Treatment of Cancer), Vieri Grandi(Peter MacCallum Cancer Centre), Anne Pham‐Ledard(Peter MacCallum Cancer Centre), Emilio Berti(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Constanze Jonak, Judit Csomor(European Organisation for Research and Treatment of Cancer), Reinhard Dummer(University Hospital of Zurich), Octavio Servitje(Bellvitge University Hospital), Sean Whittaker(Guy's Hospital), Richard Cowan(Peter MacCallum Cancer Centre), Antonio Cozzio(Ostschweizer Kinderspital), Rudolf Stadler(University Hospitals of the Ruhr-University of Bochum), Fiona Child(European Organisation for Research and Treatment of Cancer), Rachel Wachsmuth(European Organisation for Research and Treatment of Cancer)
Cited by 235
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Adjuvant Dabrafenib plus Trametinib in Stage III<i>BRAF</i>-Mutated Melanoma
|New England Journal of Medicine|2017|1.5k
Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways
|Nature Genetics|2009|1.4k